ロード中...
Therapeutic strategies for the costimulatory molecule OX40 in T-cell-mediated immunity
The T cell co-stimulatory molecule OX40 and its cognate ligand OX40L have attracted broad research interest as a therapeutic target in T cell-mediated diseases. Accumulating preclinical evidence highlights the therapeutic efficacy of both agonist and blockade of the OX40–OX40L interaction. Despite t...
保存先:
| 出版年: | Acta Pharm Sin B |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7049610/ https://ncbi.nlm.nih.gov/pubmed/32140389 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.apsb.2019.08.010 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|